Thus, in the present study, the above experimental conditions were used to examine whether omega-3 PUFAs supplemented as PLs via krill oil could beneficially affect NAFLD-related phenotypes and hepatic insulin sensitivity, and what is the potential mechanism of action. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.